Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × Drug Therapy × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 13 Breast Neoplasms 12 Neoplasms 9 Carcinoma, Squamous Cell 8 Head and Neck Neoplasms 7 Ovarian Neoplasms 6 Neoplasm Metastasis 6 Lung Neoplasms 6 Glioblastoma 6 Colorectal Neoplasms 6 Recurrence 5 Melanoma 5 Leukemia, Myeloid, Acute 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Follicular 3 Fallopian Tube Neoplasms 3 Colonic Neoplasms 3 Brain Neoplasms 3 Treatment 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Mouth Neoplasms 2 Mesothelioma, Malignant 2 Lymphoma, T-Cell, Peripheral 2

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡